Ascendis Pharma reports 52-week infant data for TransCon CNP trial
Go back to Ascendis Pharma reports 52-week infant data for TransCon CNP trial| Asianada, Inc. (NASDAQ: ASND) | Delayed: 242.99 +4.09 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.90 | 52 Week High | $21.79 | |||
| Open | $239.38 | 52 Week Low | $11.92 | |||
| Day High | $243.87 | P/E | N/A | |||
| Day Low | $236.87 | EPS | $-0.07 | |||
| Volume | 539,173 | |||||



